(ANSA) - NEW YORK, 01 DEC - The benefits of Merck's Covid pill outweigh the risks.
This is the opinion of the advisory committee of the American Food and Drug Administration, which with 13 votes in favor and 10 against, supported the Merck pill.
(HANDLE).